Skip to main content
Year archive

Hua Medicine — 2023 filings

All 39 regulatory filings released by Hua Medicine (2552) in 2023, sourced directly from the official regulator.

39 Filings
2023 Period
2023 filings (39)
Filing Released Lang
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2023-12-29 English
APPOINTMENT OF EXECUTIVE DIRECTOR
Board/Management Information
2023-12-29 English
VOLUNTARY ANNOUNCEMENT - IND APPLICATION OF 2nd GENERATION GLUCOKINASE ALLOSTERIC ACTIVATOR FILED WITH AND ACCEPTED BY FDA
Regulatory Filings
2023-12-21 English
VOLUNTARY ANNOUNCEMENT - INNOVATIVE FIRST-IN-CLASS GKA, HUATANGNING INCLUDED IN THE 2023 NATIONAL REIMBURSEMENT DRUG LIST
Regulatory Filings
2023-12-13 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2023-12-06 English
VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE ON RECEIPT OF THE MILESTONE PAYMENT UNDER THE COMMERCIALIZATION AGREEMENT IN RELATION TO HUATANGNING
Capital/Financing Update
2023-11-22 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change
2023-11-06 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2023-10-12 English
CHANGE OF NON-EXECUTIVE DIRECTOR AND CHANGE IN COMPOSITION OF REMUNERATION COMMITTEE
Board/Management Information
2023-10-12 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2023-10-06 English
INTERIM REPORT 2023
Interim / Quarterly Report
2023-09-27 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2023-09-06 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023
Interim / Quarterly Report
2023-08-24 English
BUSINESS UPDATE IN RELATION TO THE COMMERCIALIZATION OF HUATANGNING
Capital/Financing Update
2023-08-18 English
Date of Board Meeting
Report Publication Announcement
2023-08-14 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2023-08-04 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2023-07-06 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 29, 2023
Declaration of Voting Results & Voting Rights Announcements
2023-06-29 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2023-06-05 English
SUPPLEMENTAL ANNOUNCEMENT - CONTINUING CONNECTED TRANSACTION SALES AND DISTRIBUTION FRAMEWORK AGREEMENT
Regulatory Filings
2023-05-11 English
GRANT OF SHARE OPTIONS
Share Issue/Capital Change
2023-05-08 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change
2023-05-05 English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, JUNE 29, 2023
AGM Information
2023-04-27 English
(I) PROPOSED RE-ELECTION OF RETIRING DIRECTORS&#x3b;(II) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES&#x3b;(III) PROPOSED RE-APPOINTMENT OF AUDITOR&#x3b;AND (IV) NOTI
AGM Information
2023-04-27 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2023-04-27 English
Environmental, Social and Governance Report 2022
Environmental & Social Information
2023-04-27 English
Annual Report 2022
Annual Report
2023-04-27 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2023-04-11 English
CONTINUING CONNECTED TRANSACTION - SALES AND DISTRIBUTION FRAMEWORK AGREEMENT
Regulatory Filings
2023-04-10 English
GRANT OF SHARE OPTIONS
Capital/Financing Update
2023-03-31 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2023-03-31 English
RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGE IN COMPOSITION OF THE BOARD COMMITTEES
Board/Management Information
2023-03-31 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022
Annual Report
2023-03-29 English
DATE OF BOARD MEETING
Regulatory Filings
2023-03-17 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2023-03-06 English
VOLUNTARY ANNOUNCEMENT - CLARIFICATION AND UNAUDITED BUSINESS UPDATE IN RELATION TO MEDIA COVERAGE RELATING TO COMMERCIALIZATION PROGRESS OF HUATANGNING
Regulatory Filings
2023-02-16 English
VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE ON RECEIPT OF MILESTONE PAYMENTS UNDER THE COMMERCIALIZATION AGREEMENT IN RELATION TO HUATANGNING
Capital/Financing Update
2023-02-07 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2023-02-06 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2023-01-06 English